- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 25.10.24 | ME Therapeutics Holdings Inc: ME Therapeutics names Lalji chief business officer | 2 | Stockwatch | ||
| 25.10.24 | ME Therapeutics Holdings Inc. Appoints Chief Business Officer | 216 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - October 25, 2024) - ME Therapeutics Holdings Inc. (CSE:METX) (FSE:Q9T) ("ME Therapeutics" or the "Company"), a preclinical stage biotechnology company... ► Artikel lesen | |
| 22.10.24 | ME Therapeutics Holdings Inc: ME Therapeutics begins h1B11-12 cell line development | 1 | Stockwatch | ||
| 22.10.24 | ME Therapeutics Holdings Inc. Provides Research and Development Update and Corporate Update | 153 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - October 22, 2024) - ME Therapeutics Holdings Inc. (CSE: METX) (FSE: Q9T) ("ME Therapeutics" or the "Company"), a preclinical stage biotechnology company... ► Artikel lesen | |
| 18.09.24 | ME Therapeutics Holdings Inc: ME Therapeutics begins testing on mRNA formulations | 4 | Stockwatch | ||
| ME THERAPEUTICS Aktie jetzt für 0€ handeln | |||||
| 18.09.24 | ME Therapeutics Holdings Inc.: ME Therapeutics Announces the Start of Testing of First mRNA Formulations from NanoVation Therapeutics Collaboration | 239 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - September 18, 2024) - ME Therapeutics Holdings Inc. (CSE: METX) (FSE: Q9T) ("ME Therapeutics" or the "Company"), a preclinical stage biotechnology company... ► Artikel lesen | |
| 08.07.24 | ME Therapeutics Holdings Inc.: ME Therapeutics Announces New Collaboration with NanoVation Therapeutics on Advanced Therapeutic mRNA Delivery to Myeloid Cells | 358 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - July 8, 2024) - ME Therapeutics Holdings Inc. (CSE: METX) (FSE: Q9T) ("ME Therapeutics" or the "Company"), a preclinical stage biotechnology company working... ► Artikel lesen | |
| 29.05.24 | ME Therapeutics Holdings Inc. Announces the Addition of Two New Clinical Consultants to Continue the Advancement of Our Lead Anti-G-CSF Antibody Candidate Towards a First-in-Human Clinical Trial | 177 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - May 29, 2024) - ME Therapeutics Holdings Inc. (CSE: METX) (FSE: Q9T) ("ME Therapeutics" or the "Company"), a preclinical stage biotechnology company working... ► Artikel lesen | |
| 17.05.24 | ME Therapeutics Holdings Inc.: ME Therapeutics to Present at Investor Clubhouse at the Canadian Open and Attend the 2024 BIO International Convention for Partnering Opportunities | 313 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - May 17, 2024) - ME Therapeutics Holdings Inc. (CSE: METX) (FSE: Q9T) ("ME Therapeutics" or the "Company"), a preclinical stage biotechnology company working... ► Artikel lesen | |
| 15.04.24 | ME Therapeutics Holdings Inc. Announces Ringing of CSE Opening Bell on April 17, 2024 | 245 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - April 15, 2024) - ME Therapeutics Holdings Inc. (CSE: METX) (FSE: Q9T), a preclinical stage biotechnology company working on novel cancer fighting drugs... ► Artikel lesen | |
| 26.03.24 | ME Therapeutics Holdings Inc. Announces Upcoming Participation in the 2024 Bloom Burton & Co Health Care Conference and Interview On CSE TV | 189 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - March 26, 2024) - ME Therapeutics Holdings Inc. (CSE: METX) (FSE: Q9T), a preclinical stage biotechnology company working on novel cancer fighting drugs... ► Artikel lesen | |
| 06.03.24 | ME Therapeutics Holdings Inc.: ME Therapeutics Announces Closing of Non-Brokered Private Placement | 239 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - March 6, 2024) - ME Therapeutics Holdings Inc. (CSE: METX) (FSE: Q9T) ("ME Therapeutics" or the "Company"), a preclinical stage biotechnology company... ► Artikel lesen | |
| 27.02.24 | ME Therapeutics Holdings Inc.: ME Therapeutics Announces Non-Brokered Private Placement and Provides Corporate Update | 536 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - February 27, 2024) - ME Therapeutics Holdings Inc. (CSE: METX) (FSE: Q9T) ("ME Therapeutics" or the "Company"), a preclinical stage biotechnology company... ► Artikel lesen |
13 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| QUANTUM-SI | 4,285 | +0,59 % | Quantum-Si stock plunges on $50M direct offering terms | ||
| QIAGEN | 43,510 | -0,28 % | Biotech Report: Evotec legen zu, Qiagen geben ab | (shareribs.com) Frankfurt / New York 03.01.2025 - Biotech-Aktien konnten am Freitag teilweise zulegen. Für Qiagen ging es leicht abwärts. An der Wall Street tendierte der Sektor überwiegend positiv.... ► Artikel lesen | |
| TEMPUS AI | 38,260 | +11,71 % | Tempus AI, Inc.: Tempus Announces Four Abstracts Accepted For Presentation at the European Society for Medical Oncology Congress 2024 | Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced four abstracts were accepted for presentation at the... ► Artikel lesen | |
| EVOTEC | 8,540 | +2,52 % | Evotec mit EILMELDUNG: Könnte die Aktie JETZT komplett einbrechen - Extrem wichtig für Montag! | ||
| RECURSION PHARMACEUTICALS | 7,790 | +8,04 % | Recursion Pharmaceuticals (NASDAQ:RXRX) Shares Up 8.1% - Still a Buy? | ||
| STRYKER | 351,30 | +0,17 % | Dividendenbekanntmachungen (31.12.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABRDN EUROPEAN LOGISTICS INCOME PLC GB00BD9PXH49 0 GBP EUR ACADIA REALTY TRUST US0042391096 0,19 USD 0,1826 EUR ACADIAN TIMBER... ► Artikel lesen | |
| ADMA BIOLOGICS | 18,430 | +2,56 % | ADMA BIOLOGICS, INC. - 8-K, Current Report | ||
| JANUX THERAPEUTICS | 53,91 | +1,26 % | Pre-market Movers: Cheetah Net Supply Chain Service, NLS Pharmaceutics, PSQ Holdings, Janux Therapeutics, Coherus BioSciences | CANBERA (dpa-AFX) - The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 08.45 A.M. ET).In the Green Cheetah Net Supply Chain Service Inc. (CTNT) is up... ► Artikel lesen | |
| CUREVAC | 3,512 | -0,17 % | CureVac mit EILMELDUNG: Könnte die Aktie JETZT komplett einbrechen - Extrem wichtig für Montag! | ||
| COGENT BIOSCIENCES | 7,880 | +1,03 % | Cogent Biosciences, Inc.: Cogent Biosciences Announces Updated Clinical Results from SUMMIT, Showcasing Powerful Symptomatic Improvement in NonAdvanced Systemic Mastocytosis Patients | 56% mean improvement in Total Symptom Score (TSS) at 24 weeks with 76% of patients achieving at least a 50% reduction in TSS 89% of patients had >50% decrease in serum tryptase by... ► Artikel lesen | |
| SUMMIT THERAPEUTICS | 18,245 | -0,57 % | Why Is Summit Therapeutics Inc. (SMMT) Among the Best Multibagger Stocks to Buy Right Now? | ||
| BIONTECH | 112,30 | -0,09 % | Wer wird Favorit in 2025? BioNTech, Pfizer, Vidac Pharma | Der Dezember 2024 war von neuen Rekorden an den Aktienmärkten gekennzeichnet. Der Dow Jones, S&P 500, Nasdaq wie auch der DAX erreichten neue Allzeithochs. Doch einsetzende Gewinnmitnahmen und Kursabsicherungen... ► Artikel lesen | |
| CG ONCOLOGY | 30,500 | +5,28 % | CG Oncology Inc.: CG Oncology Reports Second Quarter 2024 Financial Results and Provides Business Updates | - Final positive safety and efficacy findings from CORE-001 study of Cretostimogene Grenadenorepvec in combination with Pembrolizumab in BCG-Unresponsive NMIBC simultaneously published online by Nature... ► Artikel lesen | |
| TARSUS PHARMACEUTICALS | 55,61 | +0,83 % | Tarsus Pharmaceutical - Eye Care Therapeutics | ||
| AVIDITY BIOSCIENCES | 30,600 | -1,86 % | Why Is Avidity Biosciences, Inc. (RNA) Among the Best Multibagger Stocks to Buy Right Now? |
ME THERAPEUTICS HOLDINGS INC gehört der Branche Biotechnologie an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 2,420 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ME THERAPEUTICS HOLDINGS INC finden Sie auf Wallstreet Online.
